Sylvie Davila ^UDM

Sylvie Davila is the visionary CEO and Co-founder of HERA-MI, bringing extensive expertise as a Vice President of Business and Operation in the computer medical imaging software industry. With a demonstrated history of successful engagements in clinical research, medical devices, life sciences, neurology, oncology, and CRO management, Sylvie is a seasoned business development professional with a degree from Audencia Nantes Ecole de Management. Under Sylvie's leadership, HERA-MI is at the forefront of AI research applied to medical imaging, with a specific focus on cancer diagnosis. The company's mission is to address future healthcare challenges by enhancing the healthcare system experience through AI. Sylvie and the HERA-MI team are dedicated to developing software solutions that support medical decision-making, benefiting radiologists, breast specialists, and patients alike. HERA-MI has introduced a groundbreaking medical device, Breast-SlimView®, a patented decision support software tailored for 2D and 3D mammography (tomosynthesis), specifically designed to revolutionize breast cancer screening. The AI solution, developed by HERA-MI, aims to transform diagnostic approaches, providing enhanced security and unparalleled ease of use. Sylvie Davila's leadership exemplifies a commitment to leveraging AI technology for the betterment of healthcare, particularly in the critical area of cancer diagnosis. HERA-MI's innovative solutions represent a significant contribution to the field, with Breast-SlimView® standing as a pioneering medical device in the realm of medical imaging and AI-driven decision support.